Tag Archives: Toujeo® consistently

Sanofi’s investigational therapy Toujeo® consistently showed significantly fewer low blood sugar events compared with Lantus®

Meta-analysis of three late-stage trials in people with type 2 diabetes shows decreases in risk of low blood sugar events of up to 31% at night-time compared with Lantus® All studies in the phase 3 “EDITION” clinical trial program, including a … Read the full press release